HOME >> MEDICINE >> NEWS
Mistletoe is not an anti-cancer drug, say doctors

The belief that mistletoe can help treat cancer is a myth which can cause harm, warn doctors in this week's Christmas issue of the BMJ.

The warning follows the case of a cancer patient who attended hospital with a tumour-like growth under the skin induced by mistletoe.

Some patients with cancer inject themselves mistletoe extract in the hope of improving their condition, writes complementary medicine expert, Professor Edzard Ernst in an accompanying editorial. In continental Europe, at least 30 different mistletoe preparations are available and in Germany, the insurance system pays for this treatment. A Google search also showed that 145,000 websites promote or mention mistletoe as a treatment for cancer.

So, is mistletoe an effective anticancer drug and how safe is it?

The theory that mistletoe might help treat cancer is based on the fact that, like cancer, mistletoe is a parasitic growth that eventually kills its host, says Ernst. Despite the implausibility of this idea, studies have shown that mistletoe or its main constituents do have anticancer activity. However, many plants have some sort of anticancer activity, but in most cases the compounds cannot be used.

Proponents claim that regular injections of mistletoe extract improve the natural course of cancer by slowing down or stopping tumour growth and improve quality of life.

Yet a wide range of serious adverse reactions have been noted, such as anaphylaxis, breathing difficulties, joint pain and kidney failure. Some studies even suggest that mistletoe extract may enhance the proliferation of some cancers.

So the claim that mistletoe injections have no serious risks is misleading, argues Ernst.

Mistletoe has been tested extensively as a treatment for cancer, but the most reliable trials fail to show benefit, and some reports show considerable potential for harm. The costs of regular mistletoe injections are also high.

'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
21-Dec-2006


Page: 1 2

Related medicine news :

1. New algorithm matches any tumor cells to best possible anti-cancer treatments
2. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
3. Vorinostat shows anti-cancer activity in recurrent gliomas
4. Research says boiling broccoli ruins its anti-cancer properties
5. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
6. Erectile dysfunction drugs heighten natural anti-cancer activity
7. New litmus test could aid discovery of anti-cancer drugs
8. Derivatives of cannabis for anti-cancer treatment win Kaye Award for Hebrew University student
9. Risks outweigh benefits of shark cartilage as anti-cancer treatment
10. New method of administering anti-cancer drug may be more effective, safer
11. Innovative study finds way to bio-synthesize an anti-cancer compound

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mistletoe not anti cancer drug say doctors

(Date:8/1/2015)... ... 01, 2015 , ... “ reTXT ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... clarify, edit and delete any message including ones already sent. , While text messaging ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the ... the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, ... as tried-and-true products that have stood the test of time. These include lighting ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... July 31, 2015 , ... ... started to strut their stuff, Super-Sod debuted their new type of sod called ... with registered trademark application in process. , To commemorate introduction of this new type ...
(Date:7/31/2015)... ... 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, ... is the Super Bowl. In the two weeks that separate the conference championships and the ... 2016 Super Bowl game will mark the 50th time it has been held and the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s ... It was also the first provider of Exilis non-surgical fat reduction in New York. ... it has attracted a large International clientele. Many patients travel to New York ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
(Date:7/30/2015)... N.J., July 30, 2015 PTC Therapeutics, Inc. ... and reported financial results for the second quarter ending ... on many fronts across the organization.  We are excited ... muscular dystrophy clinical trial ever conducted with topline results ... Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
Cached News: